NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Stratum Biosciences

Stratum Biosciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://stratumbio.com/

Last Round

Seed

Mar 27, 2026

Total Funding Raised

$2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stratum Biosciences is a biotechnology company that operates an AI-powered skin biology discovery platform to develop novel active ingredients and formulations for cosmetic and pharmaceutical skin products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

biotechnologyAI drug discoverydermatology researchbiobankactive ingredientsskincare formulationin silico discoveryskin biomarkersdrug discovery platformlongevity researchmolecular deliverylab-in-the-loopcosmetic sciencebiotech discoverybeauty tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratum Biosciences Comparables

Compare Stratum Biosciences with similar companies based on industry and business-model similarity.

Stratum Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Debut
77%
BELANO medical AG
63%
Givaudan
59%

Stratum Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 27, 2026

Key People

Founding team and executive leadership

Ross Lane Pearlman

Chief Executive Officer, Co-Founder

Founding Team

Stratum Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 63% QoQ, from 8 to 13 employees.

  • Apr 21, 2026

    Monthly visitors increased 62% MoM.

Stratum Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stratum Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stratum Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2024
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.